Form 4: Lemaitre Vascular Director Martha Shadan Reports Stock Transactions

Director Martha Shadan reports acquisition and disposal of Lemaitre Vascular (LMAT) common stock and dividend equivalent rights related to performance share units.

Summary

• On February 29, 2024, Martha Shadan, a director of Lemaitre Vascular Inc. (LMAT), reported transactions involving the company's common stock.
• Shadan acquired 593 shares of common stock upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022.
• She also acquired 1 share of common stock upon release of dividend equivalent rights.
• Following these transactions, Shadan directly owns 1,700 shares of LMAT common stock.
• Additionally, Shadan owns 3.998 dividend equivalent rights.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director, indicating a neutral sentiment.

Positives

• The acquisition of shares through PSU vesting suggests confidence in the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies.

Stakeholder Impact

• The transactions may have a minor impact on shareholders' perception of the company, depending on how they interpret insider activity.

Key Dates